Manganese(I) tricarbonyl complexes as potential anticancer agents. 2022

Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
Instituto de Tecnologia Química e Biológica António Xavier, ITQB NOVA, Av. da República, 2780-157, Oeiras, Portugal. oscar.rojas@itqb.unl.pt.

The antiproliferative activity of [Mn(CO)3(N^N)Br] (N^N = phendione 1, bipy 3) and of the two newly synthesized Mn complexes [Mn(CO)3(acridine)(phendione)]OTf (2) and [Mn(CO)3(di-triazole)Br] (4) has been evaluated by MTS against three tumor cell lines A2780 (ovarian carcinoma), HCT116 (colorectal carcinoma), HCT116doxR (colorectal carcinoma resistant to doxorubicin), and in human dermal fibroblasts. The antiproliferative assay showed a dose-dependent effect higher in complex 1 and 2 with a selectivity toward ovarian carcinoma cell line 21 times higher than in human fibroblasts. Exposure of A2780 cells to IC50 concentrations of complex 1 and 2 led to an increase of reactive oxygen species that led to the activation of cell death mechanisms, namely via intrinsic apoptosis for 2 and autophagy and extrinsic apoptosis for 1. Both complexes do not target DNA or interfere with cell cycle progression but are able to potentiate cell migration and neovascularization (for 2) an indicative that their application might be directed for initial tumor stages to avoid tumor invasion and metastization and opening a new avenue for complex 2 application in regenerative medicine. Interestingly, both complexes do not show toxicity in both in vivo models (CAM and zebrafish).

UI MeSH Term Description Entries
D008345 Manganese A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015027 Zebrafish An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research. Brachydanio rerio,Danio rerio,B. rerio,D. rerio,Zebra Fish,Zebra Fishes,Zebra danio,Zebrafishes,D. rerios,Fishes, Zebra,Zebra danios,danio, Zebra
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
April 2024, Chemistry (Weinheim an der Bergstrasse, Germany),
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
December 2017, Dalton transactions (Cambridge, England : 2003),
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
August 2020, Dalton transactions (Cambridge, England : 2003),
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
September 2009, Dalton transactions (Cambridge, England : 2003),
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
March 2024, Chemical science,
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
July 2022, RSC advances,
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
November 2023, Molecules (Basel, Switzerland),
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
December 2022, Inorganic chemistry,
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
August 2022, Biomaterials advances,
Oscar A Lenis-Rojas, and Beatriz Carvalho, and Rui Cabral, and Margarida Silva, and Sofia Friães, and Catarina Roma-Rodrigues, and Marta S H Meireles, and Clara S B Gomes, and Jhonathan A A Fernández, and Sabela F Vila, and Juan A Rubiolo, and Laura Sanchez, and Pedro V Baptista, and Alexandra R Fernandes, and Beatriz Royo
January 2008, Current medicinal chemistry,
Copied contents to your clipboard!